Author Update Thu, Jan. 29, 2:41 PM On Monday January 26, 2015, COV was successfully acquired by MDT at a premium to the price available when the article was published. Earlier today, APAGF was successfully acquired for $14.50 per share. The average spread was $0.49, it traded as wide as $1.47, and there was still a $0.35…
The possible reversal of the persisting low interest rate environment and modest strengthening of the key economic indicators — employment, real estate, GDP and stock market — should help insurers witness accelerated recovery in 2015. Moreover, an already strong liquidity profile, conservative product design and evolving coverage opportunity should lead the industry to an upside….
Not long ago, I told readers about all the oil floating at sea, stored on oil tankers just waiting for higher prices or a buyer. Well, now some of that of oil is on the move… to China. The beneficiaries of this development are many of the same shipping companies I mentioned before, particularly any company…
Shares of Conatus Pharmaceuticals (CNAT) tumbled as much as 40% Friday, closing the day at $6.19 per share. The company reported top line data on a phase 2 trial testing the drug Emricasan in patients with acute chronic liver failure — ACLF — and organ impairment. The drug showed an excellent reduction of key biomarkers…
Over the last five trading sessions, Video Game stocks mostly witnessed a mixed trend. While NetEase, Inc. (NTES – Snapshot Report) and Electronic Arts (EA – Analyst Report) gained momentum, Glu Mobile, Inc. (GLUU – Snapshot Report) and Zynga, Inc. (ZNGA – Snapshot Report) tumbled. Some of the major stories that grabbed headlines over the past week were the launch of Call of Duty:…
Ding! Ding! Ding! Signs of a major market top keep piling on. Pimco provides the latest bell-ringer with launch of 7 new equity strategies. Please consider Pimco Plans a Push Into Stocks. Long known as a bond powerhouse, Pacific Investment Management Co. is once again attempting an expansion into stock mutual funds. The Newport Beach, Calif.-based…
NephroGenex Inc. (NASDAQ:NRX) has announced that the Company has received positive Scientific Advice from the European Medicines Agency (EMA) regarding their Phase 3 program with Pyridorin® in diabetic nephropathy that has been accepted by the U.S. Food and Drug Administration under a Special Protocol Assessment. The EMA had cleared that the current Phase 3 program could…
The deep plunge in oil prices has been the key market theme over the past couple of months. The almost $50 a barrel share decline in oil prices has created many winners and losers in the markets. Transports like Airlines have soared while the collapse in crude has decimated much of the exploration and production…
“We who are born into this age of freedom and independence and the self must undergo this loneliness. It is the price we pay for these times of ours.” – Natsume Sôseki “The issue isn’t just jobs. Even slaves had jobs. The issue is wages.” – Jim Hightower The headline ‘Jobs Number’ came in…
2014 was a lousy year for global value investors. Cheap markets, as measured by the cyclically-adjusted price/earnings ratio (“CAPE”) got even cheaper, while expensive markets got even pricier. (Note: the CAPE takes a ten-year average of earnings as a way of smoothing out the economic cycle and allowing for better comparisons over time.) I expect…
